Cantel Medical Corp. (CMD) Position Cut by Principal Financial Group Inc.

Principal Financial Group Inc. decreased its position in shares of Cantel Medical Corp. (NYSE:CMD) by 2.5% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 274,227 shares of the company’s stock after selling 7,122 shares during the period. Principal Financial Group Inc. owned approximately 0.66% of Cantel Medical worth $25,823,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Globeflex Capital L P bought a new position in Cantel Medical in the second quarter worth approximately $114,000. LS Investment Advisors LLC purchased a new position in Cantel Medical in the second quarter worth $172,000. Airain ltd purchased a new position in Cantel Medical in the second quarter worth $201,000. Punch & Associates Investment Management Inc. purchased a new position in Cantel Medical in the second quarter worth $212,000. Finally, Riverhead Capital Management LLC purchased a new position in Cantel Medical in the second quarter worth $218,000. 84.98% of the stock is owned by institutional investors and hedge funds.

Cantel Medical Corp. (NYSE CMD) traded down $0.28 during trading hours on Wednesday, hitting $100.21. 257,963 shares of the company were exchanged, compared to its average volume of 146,503. The stock has a market cap of $4,321.89, a PE ratio of 49.70 and a beta of 1.24. Cantel Medical Corp. has a 1 year low of $69.21 and a 1 year high of $108.00. The company has a debt-to-equity ratio of 0.24, a current ratio of 2.41 and a quick ratio of 1.49.

Cantel Medical (NYSE:CMD) last released its earnings results on Thursday, September 28th. The company reported $0.54 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.52 by $0.02. Cantel Medical had a net margin of 9.27% and a return on equity of 17.60%. The company had revenue of $205.50 million for the quarter, compared to analyst estimates of $200.32 million. The firm’s revenue for the quarter was up 14.8% on a year-over-year basis. equities analysts predict that Cantel Medical Corp. will post 2.34 earnings per share for the current year.

The business also recently declared a Semi-Annual dividend, which will be paid on Wednesday, January 31st. Investors of record on Wednesday, January 17th will be paid a dividend of $0.085 per share. This is a positive change from Cantel Medical’s previous Semi-Annual dividend of $0.07. This represents a yield of 0.17%. The ex-dividend date is Tuesday, January 16th. Cantel Medical’s dividend payout ratio (DPR) is currently 8.19%.

CMD has been the topic of a number of research analyst reports. Zacks Investment Research raised shares of Cantel Medical from a “sell” rating to a “hold” rating in a report on Tuesday, August 8th. Needham & Company LLC reiterated a “hold” rating on shares of Cantel Medical in a research report on Friday, September 1st. Four analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. Cantel Medical has a consensus rating of “Hold” and an average target price of $91.67.

In other Cantel Medical news, Director George L. Fotiades sold 6,000 shares of Cantel Medical stock in a transaction dated Friday, October 13th. The shares were sold at an average price of $95.23, for a total transaction of $571,380.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Chairman Charles M. Diker sold 20,500 shares of Cantel Medical stock in a transaction dated Wednesday, October 4th. The stock was sold at an average price of $99.15, for a total transaction of $2,032,575.00. The disclosure for this sale can be found here. Insiders have sold a total of 36,368 shares of company stock worth $3,576,028 over the last quarter. 12.30% of the stock is owned by company insiders.

ILLEGAL ACTIVITY NOTICE: “Cantel Medical Corp. (CMD) Position Cut by Principal Financial Group Inc.” was originally posted by The Ledger Gazette and is owned by of The Ledger Gazette. If you are accessing this piece of content on another publication, it was illegally stolen and republished in violation of U.S. & international copyright & trademark law. The legal version of this piece of content can be accessed at https://ledgergazette.com/2017/12/07/cantel-medical-corp-cmd-shares-sold-by-principal-financial-group-inc.html.

Cantel Medical Company Profile

Cantel Medical Corp. is a provider of infection prevention products and services in the healthcare market. The Company’s operating segments include Endoscopy; Water Purification and Filtration; Healthcare Disposables, and Dialysis. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies.

Institutional Ownership by Quarter for Cantel Medical (NYSE:CMD)

Receive News & Ratings for Cantel Medical Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical Corp. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply